| Jack Joel Little, | |
|
9000 W Thunderbird Rd # 205, Peoria, AZ 85381-4451 | |
| (602) 491-1948 | |
| Not Available |
| Full Name | Jack Joel Little |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 5 Years |
| Location | 9000 W Thunderbird Rd # 205, Peoria, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669029609 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 30858 (Arizona) | Secondary |
| 225100000X | Physical Therapist | LPT-30858 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ati Holdings Of Arizona Llc | 2466732862 | 170 |
News Archive
Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function.
Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced Tibor Kovacsovics, M.D., Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies and Director of Hematologic Malignancy Clinical Research at Huntsman Cancer Institute presented a poster related to Cantex's lead compound, CX-01, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO).
"[A] recent study by the World Health Organization and the International Labor Organization identified 72 different 'social pension' plans around the world dedicated to the elderly, the ill, or the down and out," Newsweek writes in an article exploring the growth in welfare programs around the world. "Most countries on the [WHO/ILO] list are developing nations once considered too destitute to help their poor and that, until recently, had little or no welfare coverage at all.
A new report shows older people benefit from improved physical and mental health in retirement communities, resulting in cost savings to the NHS.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
› Verified 5 days ago
| Entity Name | Orthopedic & Sport Rehab Specialists At Anthem Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821109356 PECOS PAC ID: 8527961978 Enrollment ID: O20040202000051 |
News Archive
Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function.
Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced Tibor Kovacsovics, M.D., Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies and Director of Hematologic Malignancy Clinical Research at Huntsman Cancer Institute presented a poster related to Cantex's lead compound, CX-01, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO).
"[A] recent study by the World Health Organization and the International Labor Organization identified 72 different 'social pension' plans around the world dedicated to the elderly, the ill, or the down and out," Newsweek writes in an article exploring the growth in welfare programs around the world. "Most countries on the [WHO/ILO] list are developing nations once considered too destitute to help their poor and that, until recently, had little or no welfare coverage at all.
A new report shows older people benefit from improved physical and mental health in retirement communities, resulting in cost savings to the NHS.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
› Verified 5 days ago
| Entity Name | Ati Holdings Of Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1871570309 PECOS PAC ID: 2466732862 Enrollment ID: O20161130001683 |
News Archive
Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function.
Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced Tibor Kovacsovics, M.D., Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies and Director of Hematologic Malignancy Clinical Research at Huntsman Cancer Institute presented a poster related to Cantex's lead compound, CX-01, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO).
"[A] recent study by the World Health Organization and the International Labor Organization identified 72 different 'social pension' plans around the world dedicated to the elderly, the ill, or the down and out," Newsweek writes in an article exploring the growth in welfare programs around the world. "Most countries on the [WHO/ILO] list are developing nations once considered too destitute to help their poor and that, until recently, had little or no welfare coverage at all.
A new report shows older people benefit from improved physical and mental health in retirement communities, resulting in cost savings to the NHS.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jack Joel Little, 5445 Dtc Pkwy Ste 1130, Greenwood Village, CO 80111-3038 Ph: (720) 749-5599 | Jack Joel Little, 9000 W Thunderbird Rd # 205, Peoria, AZ 85381-4451 Ph: (602) 491-1948 |
News Archive
Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function.
Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced Tibor Kovacsovics, M.D., Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies and Director of Hematologic Malignancy Clinical Research at Huntsman Cancer Institute presented a poster related to Cantex's lead compound, CX-01, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO).
"[A] recent study by the World Health Organization and the International Labor Organization identified 72 different 'social pension' plans around the world dedicated to the elderly, the ill, or the down and out," Newsweek writes in an article exploring the growth in welfare programs around the world. "Most countries on the [WHO/ILO] list are developing nations once considered too destitute to help their poor and that, until recently, had little or no welfare coverage at all.
A new report shows older people benefit from improved physical and mental health in retirement communities, resulting in cost savings to the NHS.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
› Verified 5 days ago